Dr. Marijn E. Dekkers is a Chairman at Ginkgo Bioworks, Inc., an Independent Director at Quanterix Corp., a Founder & Chairman at Novalis Lifesciences LLC, a Chairman at Unilever International Holdings NV, a Member at The Business Council, a Member at The Business Roundtable and a Vice President at Bundesverband der Deutschen Industrie e.V.
He is on the Board of Directors at Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics LLC, Quanterix Corp., Foundation for the National Institutes of Health, Inc. and Georgetown University. Dr. Dekkers was previously employed as a Non-Executive Director by Unilever NV, a Non-Executive Director by Unilever Plc, an Independent Director by General Electric Co., a President by Verband der Chemischen Industrie eV, a Chairman-Management Board by Bayer AG, a Chief Executive Officer by Bayer HealthCare AG, a President, Chief Executive Officer & Director by Thermo Fisher Scientific, Inc., a Chief Operating Officer by Thermo Electron Corp., and a Head-Specialty Films & Fluorine Chemicals by Honeywell International LLC.
He also served on the board at BioQ Pharma, Inc. and Biogen Idec, Inc.
He received his undergraduate degree from Radboud University Nijmegen, a graduate degree from Technische Universiteit Eindhoven and a doctorate degree from Technische Universiteit Eindhoven.